Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2900
+0.0640 (28.32%)
Jul 28, 2026, 4:59 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 27.81 million as of July 28, 2026. Its market cap has increased by 48.76% in one year.
Market Cap
27.81M
Enterprise Value
29.60M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
ChartMarket Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 27.81M, a decrease of -71.29%. That is a compound annual growth rate of -18.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 27.81M | 177.68% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 115.33B |
| Coloplast | 90.88B |
| Demant | 57.70B |
| Gubra | 5.78B |
| BioPorto | 581.75M |
| Pharma Equity Group | 103.36M |
| ViroGates | 88.64M |